Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
disease | 0.210 | None | 0.500 | 1 | 0 | 2001 | 2008 | ||||||||
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.290 | None | 0.800 | 1 | 0 | 2005 | 2017 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.250 | None | 0.833 | 1 | 0 | 2002 | 2017 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.600 | None | 0.861 | 1 | 0 | 2001 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.600 | None | 0.875 | 1 | 0 | 2001 | 2019 | ||||||||
|
complement C5a receptor 1 | 0.513 | 0.808 | 0.40 |
|
disease | 0.270 | None | 0.875 | 1 | 0 | 2000 | 2017 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.600 | None | 0.886 | 1 | 0 | 1996 | 2019 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.600 | None | 0.900 | 2 | 0 | 1997 | 2020 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.400 | None | 0.900 | 1 | 0 | 1999 | 2019 | ||||||||
|
surfactant protein D | 0.500 | 0.846 | 7.5E-05 |
|
disease | 0.290 | None | 0.900 | 1 | 0 | 2006 | 2020 | ||||||||
|
C-C motif chemokine receptor 3 | 0.527 | 0.808 | 1.3E-04 |
|
disease | 0.400 | None | 0.909 | 1 | 0 | 1999 | 2019 | ||||||||
|
C-C motif chemokine ligand 17 | 0.518 | 0.808 | 1.4E-04 |
|
disease | 0.300 | None | 0.917 | 1 | 0 | 2001 | 2019 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.300 | None | 0.917 | 1 | 0 | 1990 | 2019 | ||||||||
|
secretoglobin family 1A member 1 | 0.546 | 0.808 | 8.0E-04 |
|
disease | 0.300 | None | 0.935 | 1 | 0 | 1998 | 2020 | ||||||||
|
T-box transcription factor 21 | 0.541 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.944 | 2 | 0 | 2002 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.300 | None | 0.947 | 1 | 0 | 1994 | 2019 | ||||||||
|
C-C motif chemokine ligand 11 | 0.473 | 0.885 | 1.0E-02 |
|
disease | 0.700 | None | 0.953 | 2 | 0 | 1995 | 2019 | ||||||||
|
interleukin 4 receptor | 0.474 | 0.846 | 2.3E-04 |
|
disease | 0.400 | None | 0.954 | 2 | 0 | 1999 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.600 | None | 0.955 | 0 | 0 | 1992 | 2020 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.300 | None | 0.957 | 1 | 0 | 2000 | 2019 | ||||||||
|
interleukin 22 | 0.393 | 0.885 | 1.9E-04 |
|
disease | 0.300 | None | 0.960 | 1 | 0 | 2009 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.300 | None | 0.963 | 1 | 0 | 1999 | 2019 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
disease | 0.600 | None | 0.964 | 3 | 0 | 1992 | 2020 | ||||||||
|
signal transducer and activator of transcription 6 | 0.475 | 0.808 | 0.99 |
|
disease | 0.400 | None | 0.965 | 2 | 0 | 1999 | 2019 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.300 | None | 0.972 | 1 | 0 | 2006 | 2020 |